Core Insights - Kinder Morgan (KMI) is expected to report quarterly earnings of $0.36 per share, reflecting a 12.5% increase year-over-year [1] - Revenue forecasts stand at $4.42 billion, indicating a 10.9% year-over-year growth [1] - The consensus EPS estimate has remained unchanged over the past 30 days, suggesting analysts have reassessed their projections [1] Earnings Estimates and Market Reactions - Changes in earnings estimates are crucial for predicting investor reactions to stock performance [2] - Empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [2] Analyst Forecasts for Key Metrics - Analysts project 'Terminals - Bulk transload tonnage' to reach 12 million tons, down from 13 million tons in the same quarter last year [4] - The 'Segment EBDA- CO2' is estimated at $150.69 million, compared to $158.00 million a year ago [5] - 'Segment EBDA- Terminals' is forecasted to be $278.21 million, slightly down from $281.00 million in the previous year [5] - 'Segment EBDA- Products Pipelines' is expected to be $302.05 million, consistent with the previous year's figure of $302.00 million [6] - 'Segment EBDA- Natural gas Pipelines' is projected to reach $1.56 billion, up from $1.39 billion in the same quarter last year [6] Stock Performance - Kinder Morgan shares have returned +4.1% over the past month, outperforming the Zacks S&P 500 composite's +2% change [6] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to mirror overall market performance in the near future [6]

Core Viewpoint - Analysts project that CSX will report quarterly earnings of $0.41 per share, reflecting a 2.4% decline year over year, with revenues expected to be $3.54 billion, indicating no change from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 3.9% over the past 30 days, indicating a collective reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts forecast 'Revenue- Coal' to reach $481.51 million, a decrease of 3.5% year over year [5]. - 'Revenue- Intermodal' is expected to be $554.16 million, reflecting a year-over-year increase of 5.4% [5]. - 'Revenue- Merchandise- Fertilizers' is projected at $137.18 million, indicating a 9.7% increase year over year [5]. - 'Revenue- Merchandise- Chemicals' is estimated to be $698.20 million, showing a decline of 1.4% from the prior year [6]. Operating Metrics - The estimated 'Operating Margin' is projected to be 67.2%, significantly higher than the year-ago figure of 31.3% [6]. - 'Revenue per unit - Intermodal' is expected to be $707.85, slightly up from $705.00 in the same quarter last year [6]. Volume Estimates - 'Volume - Merchandise - Automotive' is expected to be 92.58 thousand, down from 96.00 thousand year over year [7]. - 'Volume - Merchandise - Minerals' is projected at 87.05 thousand, compared to 88.00 thousand last year [7]. - 'Volume - Coal' is estimated at 180.65 thousand, slightly up from 179.00 thousand in the previous year [7]. - 'Volume - Merchandise - Fertilizers' is expected to reach 47.64 thousand, an increase from 44.00 thousand year over year [8]. - 'Volume - Merchandise - Metals and Equipment' is projected at 63.03 thousand, consistent with last year's figure of 63.00 thousand [8]. - 'Volume - Merchandise - Agricultural and Food Products' is estimated at 115.31 thousand, down from 116.00 thousand year over year [9]. Stock Performance - CSX shares have returned -0.9% over the past month, contrasting with the Zacks S&P 500 composite's +2% change, and the company holds a Zacks Rank 3 (Hold), indicating it is expected to mirror overall market performance [9].

Core Viewpoint - Analysts project that JPMorgan Chase & Co. will report quarterly earnings of $5.01 per share, reflecting a 4.2% year-over-year increase, with revenues expected to reach $45.71 billion, a 6.9% increase from the same quarter last year [1]. Earnings Estimates - Over the last 30 days, there has been a 1% upward revision in the consensus EPS estimate for the quarter, indicating analysts' reassessment of their initial forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior regarding the stock, as empirical studies show a strong correlation between earnings estimate trends and short-term stock performance [3]. Revenue Projections - Analysts estimate that 'Consumer & Community Banking - Revenue By Business - Card Services & Auto' will reach $7.15 billion, a year-over-year change of +3.4% [5]. - The revenue for 'Consumer & Community Banking - Revenue By Business - Banking & Wealth Management' is projected at $10.94 billion, indicating a +7.7% year-over-year change [5]. - For 'Commercial & Investment Bank - Revenue by Business - Payments', the estimate is $4.80 billion, reflecting a +2.1% change from the prior year [6]. - The total revenue for 'Commercial & Investment Bank - Revenue by Business - Total Banking & Payments' is expected to be $9.55 billion, with a +3% year-over-year change [6]. - Analysts forecast 'Commercial & Investment Bank - Revenue by Business - Fixed Income Markets' to reach $5.61 billion, indicating a +12.1% change from the year-ago quarter [7]. Key Financial Metrics - The average prediction for 'Book value per share' is $126.57, up from $116.07 a year ago [7]. - The consensus estimate for 'Total Interest Earning Assets - Average Balance' stands at $3986.42 billion, compared to $3571.96 billion a year ago [7]. - Analysts estimate 'Total Non-Performing Assets' at $11.16 billion, up from $9.29 billion in the same quarter last year [8]. - 'Total Non-Performing Loans' are projected to reach $10.54 billion, compared to $8.83 billion in the same quarter last year [9]. - The 'Tier 1 Capital Ratio' is expected to be 15.9%, down from 16.8% a year ago [9]. - The 'Total Capital Ratio' is projected to be 17.8%, compared to 18.5% in the same quarter last year [9]. Stock Performance - Shares of JPMorgan Chase & Co. have increased by +5.4% over the past month, outperforming the Zacks S&P 500 composite, which moved +0.9% [11].

Core Insights - Wall Street analysts forecast a quarterly loss of -$0.17 per share for Rubrik, Inc. (RBRK), representing a year-over-year increase of 19.1% in losses. Revenue is expected to reach $320.93 million, reflecting a 35.9% increase compared to the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted upward by 1.8%, indicating a collective reassessment by covering analysts [2]. - Revisions to earnings estimates are crucial for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Projections - Analysts predict 'Revenue- Subscription' will reach $309.06 million, indicating a year-over-year change of +39.5% [4]. - 'Revenue- Other' is expected to be $10.44 million, showing a +1.1% change from the prior-year quarter. Conversely, 'Revenue- Maintenance' is projected at $1.57 million, reflecting a significant year-over-year decline of -63.8% [5]. - 'Cloud ARR' is projected to reach $1,136,975, contrasting with the year-ago figure of $768,838 [5]. Key Company Metrics - The combined assessment suggests 'Subscription ARR' will likely reach $1,321,722, compared to $1,002,252 in the same quarter last year. Additionally, 'Customers with $100K or more in Subscription ARR' is expected to reach 2,650, up from 2,085 in the same quarter last year [6]. - Over the past month, Rubrik, Inc. shares have recorded a return of -7.9%, while the Zacks S&P 500 composite changed by -0.5%. The company holds a Zacks Rank 3 (Hold), indicating it is likely to perform in line with the overall market in the upcoming period [6].

Core Insights - Analysts project Nutanix (NTNX) will report quarterly earnings of $0.41 per share, a decline of 2.4% year over year, with revenues expected to reach $677.2 million, an increase of 14.6% from the same quarter last year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 1.8%, indicating a collective reconsideration by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts estimate 'Revenue- Support, entitlements and other services' at $326.26 million, reflecting a year-over-year change of +12.9% [5] - 'Revenue- Product' is expected to be $350.98 million, indicating a year-over-year change of +16.3% [5] - The consensus for 'Disaggregation of Revenue- Professional services revenue' stands at $29.73 million, a change of +9% from the prior-year quarter [5] - 'Disaggregation of Revenue- Subscription revenue' is projected to reach $642.75 million, with a year-over-year change of +14.6% [6] Geographic Revenue Estimates - 'Geographic Revenue- U.S.' is expected to be $379.71 million, reflecting a +14.1% change from the year-ago quarter [7] - 'Geographic Revenue- Europe, the Middle East and Africa' is projected at $162.01 million, indicating a +7.2% change [6] - 'Geographic Revenue- Other Americas' is estimated at $18.57 million, showing a significant +65.5% change [7] - 'Geographic Revenue- Asia Pacific' is forecasted to reach $114.76 million, a +19.8% change from the year-ago quarter [7] Key Metrics - The average prediction for 'Annual Recurring Revenue (ARR)' is $2.27 billion, up from $1.97 billion in the same quarter last year [8] - 'Total Billings' is expected to arrive at $715.52 million, compared to $591.40 million a year ago [8] - Analysts suggest 'Total end customers' will likely reach 29,844, an increase from 27,160 in the same quarter last year [9] Stock Performance - Nutanix shares have returned -12.2% over the past month, contrasting with the Zacks S&P 500 composite's -0.3% change [9] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to mirror overall market performance in the near future [9]

Core Viewpoint - Analysts project that Dolby Laboratories (DLB) will report quarterly earnings of $0.70 per share, reflecting a year-over-year decline of 13.6%, with revenues expected to reach $305.38 million, a slight increase of 0.2% from the same quarter last year [1]. Revenue Estimates - The consensus estimate for 'Revenue- Licensing' is $280.87 million, indicating a decrease of 0.7% from the prior-year quarter [4]. - 'Revenue- Products and services' is expected to be $24.50 million, showing an increase of 10.9% from the year-ago quarter [4]. - 'Revenue- Licensing- Market- PC' is projected at $27.12 million, suggesting a decline of 20.4% year over year [4]. - 'Revenue- Licensing- Market- Other' is anticipated to reach $78.82 million, reflecting an increase of 26.9% from the prior-year quarter [5]. - 'Revenue- Licensing- Market- CE' is expected to be $30.72 million, indicating a decrease of 26.9% from the year-ago quarter [5]. - 'Revenue- Licensing- Market- Broadcast' is projected at $91.88 million, showing a decline of 4.1% from the prior-year quarter [6]. - 'Revenue- Licensing- Market- Mobile' is expected to be $53.77 million, reflecting an increase of 10.4% from the year-ago quarter [6]. Gross Margin Estimates - 'Gross Margin- Licensing' is estimated at $260.57 million, compared to $263.94 million from the previous year [7]. - 'Gross margin- Products and services' is projected to reach $2.30 million, down from $6.87 million reported in the same quarter last year [7]. Stock Performance - Dolby Laboratories shares have decreased by 2.8% over the past month, contrasting with the Zacks S&P 500 composite's increase of 4.6% [7].

Core Insights - Groupon reported revenue of $122.83 million for Q3 2025, a year-over-year increase of 7.3%, but an EPS of -$2.92 compared to $0.33 a year ago, indicating significant losses [1] - The revenue exceeded the Zacks Consensus Estimate of $121.88 million by 0.77%, while the EPS fell short of the consensus estimate of $0.01 by 29300% [1] Financial Performance - The company’s stock has returned -7.5% over the past month, contrasting with the Zacks S&P 500 composite's +1.3% change, and currently holds a Zacks Rank 3 (Hold) [3] - North America revenue was $96.01 million, surpassing the two-analyst average estimate of $92.32 million, reflecting a year-over-year change of +10.5% [4] - International revenue was $26.82 million, slightly below the two-analyst average estimate of $27.62 million, showing a year-over-year decline of -2.8% [4] Geographic Revenue Breakdown - North America Local revenue reached $91.56 million, exceeding the average estimate of $87.82 million, with a year-over-year increase of +12.4% [4] - International Goods revenue was $2.18 million, below the average estimate of $2.84 million, marking a year-over-year decrease of -20.5% [4] - North America Goods revenue fell to $1.22 million, significantly lower than the estimated $1.63 million, representing a -50.9% change year over year [4] - International Local revenue was $23.18 million, slightly above the average estimate of $23.15 million, with a year-over-year change of -1.2% [4] - International Travel revenue was $1.46 million, below the average estimate of $1.63 million, but showing a year-over-year increase of +5.6% [4] - North America Travel revenue increased to $3.22 million, surpassing the estimated $2.87 million, reflecting a +10.4% change year over year [4]

Core Insights - Bio-Techne Corporation (TECH) reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of 42 cents, matching the Zacks Consensus Estimate, with the bottom line remaining flat year-over-year [1][9] - The company's net sales for the quarter were $286.6 million, down 1% year-over-year, missing the Zacks Consensus Estimate by 0.9%, leading to a 7.5% drop in shares during pre-market trading [3][9] Financial Performance - GAAP loss per share was 24 cents compared to EPS of 21 cents in the prior-year quarter [2] - Gross profit increased by 2.8% to $188.1 million, with gross margin expanding by 242 basis points to 65.6% due to a 7.5% decrease in the cost of sales [6][9] - Operating profit for the quarter was $47.7 million, up from $40 million in the year-ago quarter, with an operating margin expansion of 282 basis points to 16.6% [7][9] - Net cash provided by operating activities was $27.6 million, down from $63.9 million a year ago [10] Revenue Breakdown - In the Protein Sciences segment, revenues were $202.2 million, down 1% year-over-year (down 3% organically) [4] - The Diagnostics and Spatial Biology segment saw sales decrease by 4% year-over-year to $79.5 million, although it was up 3% organically [5] Market Position and Outlook - Despite the revenue decline, there are signs of stabilization in the U.S. academic market and continued strength among large pharmaceutical customers [11] - The expansion of both gross and operating margins is viewed as a positive indicator for the company's future performance [12]

Core Insights - Analysts project that JFrog Ltd. (FROG) will report quarterly earnings of $0.16 per share, reflecting a year-over-year increase of 6.7% [1] - Revenue is expected to reach $128.4 million, marking a 17.7% increase from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' assessments [1] Revenue Estimates - 'Revenue- License- self-managed' is estimated at $5.71 million, showing a year-over-year change of +2.6% [4] - 'Revenue- Subscription- self-managed and SaaS' is projected to be $122.50 million, indicating an 18.4% year-over-year increase [4] - 'Revenue- Subscription- SaaS' is expected to reach $58.03 million, reflecting a significant change of +37% from the previous year [4] Subscription Metrics - The estimated 'Revenue- Self-managed subscription' stands at $70.29 million, suggesting a year-over-year increase of +5.4% [5] - Analysts predict that the number of 'Customers >$100k in ARR' will rise to 1,107, compared to 966 in the previous year [5] Market Performance - JFrog shares have experienced a -2% change in the past month, contrasting with a +1% move of the Zacks S&P 500 composite [5] - With a Zacks Rank 2 (Buy), FROG is anticipated to outperform the overall market in the near future [5]

Core Insights - Robinhood Markets (HOOD) is set to announce its Q3 earnings results on November 5th, focusing on net deposits [5] - The consensus GAAP EPS estimate for the quarter is $0.54, while the consensus revenue estimate stands at $1.22 billion, reflecting a year-over-year increase of 91.5% [5]